Authors


Mohan Nair, MD

Latest:

Ketamine and Psychedelics: The Journey From Magical Mystery to Informed Consent

In this CME article, learn more about the best practices for engaging patients in the informed consent process for psychedelic treatment and psychedelic-assisted psychotherapy.


Frank Chen, MD

Latest:

Long-Acting Injectable Antipsychotics in the Era of COVID-19

COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.


Marco Mula, MD, PhD, FRCP, FEAN

Latest:

Psychiatric Comorbidities in Epilepsy: Implications for Clinical Practice

Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.


Mona Mojtahedzadeh, MD

Latest:

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.


Jeremy Barnett, LMHC, CASAC

Latest:

Keeping the Holiday Spirit (Without the Holiday Spirits)

Tips for helping patients preserve their sobriety through the holiday season


David Seigler, MD, FAPA

Latest:

Reentry Anxiety

Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?


Nick Rushworth

Latest:

Violence Against Women and Acquired Brain Injuries

Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.


Donald E. McLawhorn, Jr, MD, PhD

Latest:

Trauma and Transition Trajectories: The Risk of Caenisian Reversion

How can you best address and support transgender patients, as well as prevent negative outcomes?


Laszlo Gyulai, MD

Latest:

Treating Mania in Older Adults With Bipolar Disorder

In older adults with bipolar disorder, what evidence is there to guide treatment?


James T. Hackett

Latest:

Telling Humanity’s Brain Story: Insights From Brain Capital

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?


Tanuja Gandhi, MD

Latest:

Creating a Safe Space for Grieving Children

For children who feel left alone in the world after profound loss, there are ways to mitigate the harm.


Molly Zhang, MSc (Cand)

Latest:

Intimate Partner Violence Victimization: How It Relates to Substance Use in Women

In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.


Gregg F. Martin, PhD, Major General, US Army (Retired)

Latest:

VIP Medicine: A Double-Edged Sword

What happens when patients receive special treatment based on their rank or relationships? Two survivors share their stories.


Mostashara Center for Psychological and Social Health

Latest:

Earthquake Relief Efforts: Frontline Heroes

We connected with a group working on the frontlines of Southern Turkey and Northern Syria to assist the survivors of the devastating earthquake.



Richard F. Mollica, MD, MAR

Latest:

Moving Beyond the Enormity Problem: Tackling the Global Refugee Crisis

Collective trauma: psychiatry can play a major role in addressing public anxiety and fear.


Margaret S. Chisolm, MD, FAMEE, FACP, FAAP

Latest:

From Survive to Thrive

How can clinicians help patients get well, stay well, and reach their full potential?


Susan Inman

Latest:

Being an American Canadian Mother of a Daughter With Schizophrenia

This mother shares her experience of having a loved one with schizophrenia, and the difference location can make in treatment.


Paul Weigle, MD

Latest:

Dopamine Detoxification for Problematic Gaming

Problematic gaming is challenging to treat. Here's how you can get started.



Hannah Simon, MD

Latest:

How to Talk to Teenagers About Substance Use

Scare tactics don’t work. But scientific education might. Here are tips for talking with teenaged patients about keeping themselves and their friends safe.


Rania Awaad, MD

Latest:

Psychiatrists Concerned With the Afghanistan Situation: Ethical and Practical Issues

What can psychiatrists do to help veterans, Muslims, immigrants, refugees, and all those affected by the US withdrawal?


Mitch Medley

Latest:

Keeping the Scales Balanced

A behavior analyst shares his stories and information on establishing appropriate replacement behaviors for patients with traumatic brain injuries and problematic behavior.


Sasidhar Gunturu, MD

Latest:

HIV-Associated Neurocognitive Disorder: An Updated Pathophysiology

In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.


Wayne Hellstrom, MD

Latest:

Sex, Drugs, and Psychosis: Reviewing Psychiatric Medications’ Taboo Side Effect

The sexual side effects of psychiatric medications are troubling enough that some patients consider treatment cessation. The authors review 5 strategies for managing sexual dysfunction.


Colleen A. Sloan, PhD

Latest:

Validation of Minoritized Experiences: It’s What’s Been Missing

Interventions that rely solely on change lack balance. This is especially true when working with minoritized individuals who have very real and justified pain stemming from systemic problems.


Jeremy Kranz

Latest:

Move Over Data, Brain Capital is the New Oil

What consequences will big data and artificial intelligence have on brain health and economics?


Andrew Wister, PhD

Latest:

Building Brain Resilience: A Multi-Level Systems Approach

Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.


Jeff Sugar, MD

Latest:

Some Words for the Graduates

One psychiatrist shares some words of wisdom for the class of 2022.


Ben Greenberg, MD, PhD

Latest:

An Update on Neuromodulation

What are some of the most exciting emerging and established methods?

© 2024 MJH Life Sciences

All rights reserved.